Exam 2 (Drugs 51 - 100) Flashcards

(216 cards)

1
Q

Venlafaxine HCl

A

Effexor (XR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Potent inhibitor of neuronal 5-HT & NE reuptake

A

Venlafaxine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Do not begin within 14 days of D/C MAOI. Also, wait to start an MAOI until at least 7 days after D/C this drug.

A

Venlafaxine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ANTIDEPRESSANTS INCREASE SUICIDAL THOUGHTS AND ACTIONS IN SOME CHILDREN AND TEENAGERS

A

Venlafaxine, Mirtazapine, Paroxetine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Continued therapy of up to 2 weeks may be needed to show noticeable improvement

A

Venlafaxine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clonidine HCl

A

Catapres (TTS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Stimulates central alpha-adrenergic receptors resulting in inhibition of bulbar sympathetic cardioaccelerator and sympathetic vasoconstrictor centers

A

Clonidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Dangerous increases in BP when used with beta-blockers and when either drug is D/C

A

Clonidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Sudden cessation of therapy may produce severe HTN

A

Clonidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Change transdermal skin sites with each application

A

Clonidine-TTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Aripiprazole

A

Abilify

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MOA is a combination of partial agonist activity at dopamine D2 and 5-HT1A receptors & antagonist activity at 5-HT2A receptors

A

Aripiprazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CI IN PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS

A

Aripiprazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Rare cases of Neuroleptic Malignant Syndrome (NMS) have occurred in patients taking this med

A

Aripiprazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

TARDIVE DYSKINESIA is a rare possibility in patients taking this drug

A

Aripiprazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Use appropriate precautions against heat exposure and dehydration

A

Aripiprazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Store oral solution in the refrigerator and use within 6 months of opening the bottle

A

Aripiprazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Lisinopril with HCTZ

A

Zestoretic, Prinzide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Electrolyte disturbances may cause DIGITALIS-induced arrhythmias

A

Lisinopril w/HCTZ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

CI in patients with a history of angioedema related to a previous treatment with an ACEI

A

Lisinopril w/HCTZ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Timing of dose is important bc of increased diuresis. Usually given in the early AM.

A

Lisinopril w/HCTZ, Spironolactone, Triamterene with HCTZ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Morphine Sulfate (extended release)

A

MS Contin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Produces analgesia by a central action on the central opiate receptors

A

Morphine sulfate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

CI in patients with respiratory depression in the absence of resuscitative equipment, and in patients with acute or severe bronchial asthma. Also CI in any patient with a paralytic ileus.

A

Morphine sulfate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Fenofibrate
Tricor
26
Lowers total cholesterol, LDL, and triglycerides by activation of peroxisome proliferator activated receptor-a (PPARa).
Fenofibrate
27
Avoid use in conjunction with HMG-CoA reductase inhibitors as this can lead to serious AE's (rhabdomyolysis)
Fenofibrate
28
CI in patients with hepatic or severe renal dysfunction, including primary biliary cirrhosis, in patients with unexplained persistent liver function abnormality, and in patients with preexisting gallbladder disease
Fenofibrate
29
Serious liver toxicity is a potential AE of this drug therapy
Fenofibrate
30
Promptly report RASH, MUSCLE PAIN, TENDERNESS, or WEAKNESS (signs of myositis)
Fenofibrate
31
Important to closely follow prescribed diet with this medication
Fenofibrate
32
Rosuvastatin Calcium
Crestor
33
Selective, competitive inhibitor of HMG-CoA reductase
Rosuvastatin, Pravastatin
34
CI in patients with active liver disease or with unexplained persistent elevations of serum transaminases and during pregnancy and lactation
Rosuvastatin, Pravastatin
35
Azithromycin Dihydrate
Zithromax & Zmax
36
A macrolide antibiotic that binds to the 50S ribosomal subunit of susceptible bacteria thereby suppressing protein synthesis
Azithromycin
37
Pseudomembranous colitis and secondary bacterial infections may occur with broad spectrum abx
Azithromycin
38
Do not use for complicated pneumonia, gonorrhea, or syphilis
Azithromycin
39
Do not take antacids within 1 hour of administration (slow drug absorption)
Azithromycin
40
Pravastatin Sodium
Pravachol
41
Grapefruit juice has little to no effect on plasma levels
Pravastatin
42
May cause optic nerve degeneration
Pravastatin
43
Avoid overexposure to sunlight due to possibility of photosensitivity. Use a sunscreen and wear appropriate clothing until the level of sensitivity is determined.
Pravastatin
44
Naproxen
Naprosyn
45
MOA probably due to inhibition of cyclooxygenase resulting in decreased biosynthesis of prostaglandins
Naproxen
46
NSAID's may produce serious GI toxicity with or without warnings
Naproxen
47
May require up to 2 weeks to see noticeable improvement in arthritic conditions
Naproxen
48
Concurrent ingestion of alcohol may increase ulcerogenic effect
Naproxen
49
Tamsulosin HCl
Flomax
50
Selective alpha-adrenergic blocking agent for receptors found in the prostate (used in BPH). Blocking these receptors relaxes the prostate gland and bladder neck to result in increased urinary flow and a reduction in BPH symptoms.
Tamsulosin
51
Orthostatic hypotension may occur during therapy, therefore patients should be warned about possible syncope and dizziness
Tamsulosin
52
Take dose 1/2 hour following the same meal every day
Tamsulosin
53
Divalproex Sodium
Depakote (ER)
54
MOA thought to be related to increased brain levels of GABA
Divalproex
55
CI in patients with hepatic disease (hepatic failure resulting in fatalities has occurred in patients receiving this drug)
Divalproex
56
Capsules may be swallowed whole or the contents sprinkled over soft food and ingested without chewing
Divalproex
57
Donepezil HCl
Aricept
58
A reversible acetylcholinesterase inhibitor that works centrally to increase the amount of acetylcholine available at cholinergic synapses
Donepezil
59
CI in patients with known hypersensitivity to the drug or piperidine derivatives
Donepezil
60
May be beneficial to D/C use prior to known anesthesia. May cause vagotonic effects on the heart therefore use caution in patients with sick sinus syndrome. May increase gastric acid secretion therefore use caution in patients prone to ulcers or GI bleeding
Donepezil
61
Take in the evening, just prior to retiring. May be taken with or without food
Donepezil
62
Ibuprofen
Motrin
63
Produces a reversible inhibition of cyclooxygenase which results in a decreased synthesis of prostaglandins
Ibuprofen
64
Not recommended in pregnancy due to the known effects of this class of drugs on the human fetal cardiovascular system (closure of the ductus arterioles)
Ibuprofen
65
Pregabalin
Lyrica
66
High binding affinity to the alpha(2)-delta site in CNS tissues
Pregabalin
67
When discontinuing therapy, taper gradually over a minimum of 1 week
Pregabalin
68
Peripheral edema has been reported, especially in patients also taking thiazolidinedione antidiabetic agents
Pregabalin
69
Oral solution must be used within 45 days of opening the stock container
Pregabalin
70
Lamotrigine
Lamictal (XR)
71
MOA unknown - may be due to inhibition of voltage-sensitive sodium channels, resulting in a stabilization of neuronal membranes and modulation of presynaptic transmitter release of excitatory amino acids (glutamate & aspartate)
Lamotrigine
72
Use with ORAL CONTRACEPTIVES may decrease the serum concentrations of the progestin component while significantly decreasing the serum concentration of this drug
Lamotrigine
73
Serious life-threatening rashes have been reported in association with the use of this drug. Rashes usually occur within the first two weeks of therapy and are more common in pediatric patients.
Lamotrigine
74
Chewable tablets may be chewed or dispersed in a teaspoonful of water or diluted fruit juice
Lamotrigine
75
Alendronate Sodium
Fosamax
76
Adheres to sites of bone resorption inhibiting osteoclast activity
Alendronate
77
As a general rule, do not administer any oral medication within 30 minutes of this drug
Alendronate
78
CI in patients with abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia, in patients who cannot sit upright or stand for at least 30 minutes, and in patients with hypocalcemia. Can cause severe local irritation of the upper GI mucosa
Alendronate
79
Must be swallowed with 6 - 8 ounces of plain water immediately upon arising for the day (at least 30 minutes before the first food, beverage, or medication for the day). Do not lie down for 30 minutes after swallowing the tablet and not until the first food of the day has been consumed.
Alendronate
80
Isosorbide mononitrate (antianginal)
Imdur
81
Acts by reduction of myocardial oxygen demand through the relaxation of vascular smooth muscle
Isosorbide
82
CI in patients who are hypersensitive to nitrates
Isosorbide
83
Use is not recommended in acute phase of MI or in those with congestive HF. Use with caution in patients with hypotension or volume depletion.
Isosorbide
84
Tolerance and physical dependence may occur after prolonged use
Isosorbide
85
Most common AE's include headache (50%) and dizziness (10%)
Isosorbide
86
May cause dizziness, headache, or flushing. Headaches are a sign of drug effectiveness. Do not adjust dosage to treat headaches - use aspirin or APAP as needed.
Isosorbide
87
Spironolactone
Aldactone
88
Works by competitive antagonism of aldosterone, primarily at the aldosterone-dependent Na+/K+ exchange sites in the distal convoluted renal tubule
Spironolactone
89
CI in patients with anuria, acute renal insufficiency, significant impairment of renal function, hyperkalemia, and in patients hypersensitive to sulfonamides
Spironolactone
90
Common AE's include WEAKNESS, PARESTHESIA, MENTAL CONFUSION, DRY MOUTH, & MUSCLE CRAMPS
Spironolactone
91
Losartan Potassium
Cozaar
92
Blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor found in many tissues (ARB)
Losartan
93
Glipizide
Glucotrol (XL)
94
A sulfonylurea antidiabetic medication that stimulates insulin synthesis and release from beta cells in the pancreatic islets
Glipizide
95
CI in juvenile, unstable (labile), or complicated DM as the sole therapy, in patients allergic to sulfa drugs, and in diabetic ketoacidosis with or without coma
Glipizide, Glyburide
96
In patients with severe burns, infections, or trauma, this drug may need to be D/C and insulin given
Glipizide, Glyburide
97
Mild hypoglycemic reactions (sweating, tremor, blurred vision, weakness, hunger, and confusion) may occur rarely and should be treated with oral glucose
Glipizide, Glyburide, Glimepiride
98
Take 30 minutes prior to meals. Compliance with therapy is essential for optimum effect. Follow prescribed diet closely. Avoid excessive use of alcohol.
Glipizide
99
Risperidone
Risperdal
100
Thought to act by direct antagonism of dopamine (D2) and serotonin (5-HT2) receptors in the CNS
Risperidone
101
CI IN PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS. Antipsychotic drugs have produced a potentially fatal symptom complex called neuroleptic malignant syndrome (NMS). Do not dispense large quantities of this drug to suicidal patients.
Risperidone
102
EXTRAPYRAMIDAL SYMPTOMS & TACHYCARDIA are two big AE's of this drug
Risperidone
103
May cause fainting with initial doses - use caution when getting up from a sitting or lying position. Solution is compatible with orange juice, coffee, and low-fat milk.
Risperidone
104
M-Tab tablets must be used immediately after opening their blister. Do not try to push the tablet through the blister. Open with dry hands and do not try to split or store tablets after the blister is opened.
Risperidone
105
Carisoprodol
Soma
106
May work centrally in the spinal cord or the descending reticular formation to produce muscle relaxation. The metabolite is meprobamate.
Carisoprodol
107
CI in acute intermittent porphyria (rare disease in which hemoglobin is abnormally metabolized)
Carisoprodol
108
Ropinirole HCl (antiparkinson)
Requip (XL)
109
A non-ergoline dopamine agonist with full intrinsic activity at the D2 & D3 dopamine receptor subtypes
Ropinirole
110
Patients have reported sudden initiation of sleep without warning. This has occurred during normal activities of daily living, including the operation of vehicles.
Ropinirole
111
Cigarette smoking decreases AUC by 38%. Inform the physician if planning to start or stop smoking
Ropinirole
112
If being taken for Parkinson's disease, do not stop therapy abruptly; treatment should be tapered over time
Ropinirole
113
Diazepam
Valium
114
Facilitates the inhibitory neurotransmitter action of GABA, which mediates both pre- and post-synaptic inhibition in all regions of the CNS
Diazepam
115
CI in patients with myasthenia gravis, severe respiratory insufficiency, severe hepatic insufficiency, in sleep apnea, in children under the age of 6 months, in narrow-angle glaucoma, and in untreated open-angle glaucoma
Diazepam
116
Oral concentrate must be diluted prior to use
Diazepam
117
Allopurinol
Zyloprim
118
Competitively inhibits xanthine oxidase which is the enzyme responsible for the conversion of hypoxanthine to xanthine to uric acid
Allopurinol
119
Gout attacks may increase during initiation of therapy. Use colchicine or NSAIDs prophylactically
Allopurinol
120
A sufficient fluid intake (to yield urine output of 2 liters per day) and the maintenance of a neutral to slightly alkaline urine are recommended to avoid the formation of xanthine calculi and to help prevent renal precipitation of urates in patients receiving concomitant uricosuric agents.
Allopurinol
121
Compliance with therapy is essential. May take one or more weeks to reach maximum effectiveness. High fluid intake during therapy is beneficial to help prevent kidney stone formation.
Allopurinol
122
Mirtazapine
Remeron
123
Antagonist of central presynaptic alpha-2 adrenergic inhibitory auto receptors and heteroreceptors, an action that is postulated to result in an increase in central noradrenergic and serotonergic activity
Mirtazapine
124
SolTabs must be used immediately upon opening individual tablet blisters
Mirtazapine
125
Oxybutynin Chloride (oral) (urinary bladder modifier)
Ditropan (XL)
126
Inhibits the muscarinic action of acetylcholine on smooth muscle. Blockage does not occur at skeletal neuromuscular junctions or autonomic ganglia. Relaxes bladder smooth muscle which decreases urgency, frequency, urinary leakage, and dysuria.
Oxybutynin
127
CI in uncontrolled narrow-angle glaucoma, urinary retention, and gastric retention
Oxybutynin
128
Heat prostration can occur in the presence of high environmental temperature. Avoid prolonged exposure to hot weather.
Oxybutynin
129
The semipermeable membrane tablet shell of the extended-release tablets passes through the GI tract intact and may be found in the stool
Oxybutynin
130
Pioglitazone HCl
Actos
131
A thiazolidinedione antidiabetic agent that decreases insulin resistance by improving target cell response to insulin (requires presence of insulin)
Pioglitazone
132
CI in patients with NYHA Class III or IV HF. Can exacerbate congestive HF. Because it requires insulin, do not use in T1DM
Pioglitazone
133
Quarterly HbA1c testing should be performed
Pioglitazone
134
Memantine HCl
Namenda (XR)
135
Works as a low to moderate affinity uncompetitive (open-channel) NMDA receptor antagonist
Memantine
136
Daily doses above 5 mg should be given BID and dose increases should not be made sooner than once a week
Memantine
137
Metoclopramide HCl
Reglan
138
MOA as an antiemetic is due to an inhibition of dopamine receptors which results in decreased nerve transmission from afferent nerves to the vomiting center and an increase in the vomiting center threshold
Metoclopramide
139
MOA as a GI motility stimulant is thought to be caused by an imbalance between dopaminergic and cholinergic actions in the GI tract through inhibition of dopamine induced gastric smooth muscle relaxation
Metoclopramide
140
CI in patients with pheochromocytoma, GI hemorrhage, mechanical obstruction or perforation, and in epilepsy. Do not use in patients receiving drugs that may cause EPS.
Metoclopramide
141
AE's include restlessness, drowsiness, tardive dyskinesia, and fatigue
Metoclopramide
142
Take 30 minutes before meals (in order to achieve effects as a GI motility stimulant)
Metoclopramide
143
Baclofen
Lioresal
144
An analog of GABA, most likely works at the spinal cord level, reducing both the flexor and extensor spasms
Baclofen
145
Do not D/C abruptly due to risk of hallucinations and seizures
Baclofen
146
Phenylketonurics should be warned that orally-disintegrating tablets contain phenylalanine
Baclofen
147
Folic Acid (Folacin, Pteroylglutamine Acid; Folate)
No brand name
148
An important vitamin required for the synthesis of thymidylate, synthesis of purine nucleotides, and for maintenance of normal erythropoiesis. Deficiency can lead to megaloblastic anemias in adults and children & neural tube defects in unborn infants
Folic Acid
149
CI in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient
Folic Acid
150
The US Public Health Services recommends the use of 0.4 mg of folic acid in women of childbearing age to reduce the incidence of neural tube defects.
Folic Acid
151
Amoxicillin Trihydrate
Amoxil, Moxatag, Trimox
152
Inhibits bacterial cell wall synthesis via acylation of the transpeptidase enzyme
Amoxicillin
153
Changes in GI flora may disrupt the absorption of oral contraceptives
Amoxicillin
154
CI in patients hypersensitive to PCNs and/or cephalosporins. Incidence of cross-sensitivity is 5 - 16%
Amoxicillin
155
AE's are DIARRHEA, RASH, N/V, hives, itching
Amoxicillin
156
Preferably taken on an empty stomach 1 hour before or 2 hours after meals with a full glass (240 mL) of water. Take at even intervals, preferably around the clock
Amoxicillin
157
Keep suspension refrigerated. Discard after 14 days
Amoxicillin
158
Amphetamine with Dextroamphetamine Salts
Adderall (XR)
159
MOA in ADD is unknown. Causes CNS stimulation by a direct action on adrenergic receptors, releasing norepinephrine from storage sites
Adderall
160
CI in advanced arteriosclerosis, CV disease, moderate HTN, hyperthyroidism, agitated states, glaucoma, and within 14 days of therapy with MAOI's. Do not use in patients with known history of drug abuse.
Adderall
161
Buspirone HCl
BuSpar
162
Exact MOA is unknown - may be due to a number of changes in brain chemistry including 1) increasing the metabolism of NE in the locus ceruleus, 2) acting as a moderate presynaptic dopamine agonist, 3) acting as a serotonin agonist
Buspirone
163
Because of this drug's ability to bind to dopamine receptors, there is a possibility of dystonia, parkinsonism, and tardive dyskinesia occurring during therapy
Buspirone
164
Glyburide
Micronase, Diabeta
165
Stimulates insulin synthesis and release from beta cells in the pancreatic islets
Glyburide, Glimepiride
166
Take with breakfast or the first main meal. Compliance with therapy is essential for optimum effect
Glyburide, Glimepiride
167
Promethazine HCl
Phenergan
168
Competitively inhibits histamine at the H1 receptor site causing a spasmolytic and decongestant effect
Promethazine
169
CI in patients with hypersensitivity to other phenothiazines and in patients with lower respiratory tract symptoms (including asthma). CI in pediatric patients
Promethazine
170
Levetiracetam
Keppra
171
A pyrolidine derivative that is chemically unrelated to existing anti epileptic drugs. Inhibits burst firing in the hippocampus without affecting normal neuronal excitability
Levetiracetam
172
No known clinically significant drug interactions exist
Levetiracetam
173
Therapy should be withdrawn slowly to minimize the potential of triggering a seizure
Levetiracetam
174
Could cause hostility and nervousness, in addition to somnolence, asthenia, infection, and dizziness
Levetiracetam
175
Sulfamethoxazole with Trimethoprim
Bactrim, Septra
176
________ blocks the production of tetrahydrofolic acid by inhibiting the enzyme dihydrofolate reductase. ________ inhibits bacterial synthesis of dihydrofolic acid by competitive antagonism of PABA
Bactrim
177
CI in infants < 2 months of age, during pregnancy, in nursing mothers, in patients allergic to sulfa drugs, and in patients with megaloblastic anemia due to folate deficiency
Bactrim
178
Increased sensitivity to sunlight, Stevens-Johnson Syndrome, N/V, DIARRHEA, dizziness, anorexia, and RASH
Bactrim
179
Preferably taken on an empty stomach one hour before or two hours after meals with a full glass (240 mL) of water. Avoid prolonged exposure to sunlight.
Bactrim
180
Pantoprazole Sodium
Protonix
181
A PPI that suppresses the final step in gastric acid production by forming a covalent bond to two sites of the (H+, K+)-ATPase enzyme system at the secretory surface of the gastric parietal cell
Pantoprazole
182
Antacids may be taken at the same time as this drug.
Pantoprazole
183
Digoxin (inotropic agent)
Lanoxin, Lanoxicaps, Digitek
184
Digitalis glycosides inhibit membrane bound Na+/K+ ATPase resulting in an increased intracellular Na+ concentration and a slightly decreased intracellular K+ concentration
Digoxin
185
CI in patients with ventricular fibrillation
Digoxin
186
AE's include anorexia, N/V, gynecomastia, blurred vision, HA, and bradycardia
Digoxin
187
Do not take any nonprescription cough or cold medicines, antacids, laxatives, or antidiarrheals without first consulting your pharmacist or physician
Digoxin
188
Lidocaine (transdermal)
Lidoderm
189
Exhibits neuronal membrane-stabilizing properties by combining with fast sodium channels during their inactive state to inhibit repolarization
Lidocaine
190
CI in patients with a known hypersensitivity to local anesthetics of the amide type
Lidocaine
191
Excessive dosing by using more than 3 patches per day or by using for longer than the recommended 12 hours may lead to increased absorption and high blood concentrations. Do not apply to broken or inflamed skin
Lidocaine
192
The most common AE's of this medication are topical in nature (erythema, bruising, edema, papules, vesicles, discoloration, burning, pruritis, dermatitis, petechia, blisters, and exfoliation)
Lidocaine
193
Wash hands after the handling of this medication. If irritation or a burning sensation occurs during application, remove the patch and do not reapply until the irritation subsides. Do not use external heat sources such as electric blankets or heating pads. Do not leave patches on for more than 12 hours within a 24 hour period.
Lidocaine
194
Tolterodine Tartrate
Detrol (LA)
195
Competitive muscarinic receptor antagonist. Effects on the bladder include an increase in residual urine, reflecting an incomplete emptying of the bladder, and a decrease in detrusor pressure
Tolterodine
196
CI in patients with urinary retention, gastric retention, uncontrolled narrow-angle glaucoma, or hypersensitivity to any ingredient
Tolterodine
197
Most common AE's include dry mouth, HA, dizziness, constipation, dyspepsia, and somnolence
Tolterodine
198
Triamterene with HCTZ
Dyazide, Maxzide
199
Inhibits the reabsorption of sodium in exchange for potassium at the distal renal tubule
Triamterene with HCTZ
200
CI in patients with anuria, hyperkalemia, hypersensitivity to sulfonamide-derived drugs, or patients currently taking other potassium-sparing diuretics
Triamterene with HCTZ
201
AE's include dry mouth, MUSCLE CRAMPS, N/V, WEAKNESS, dizziness, orthostatic hypotension, GI distress including diarrhea and constipation, hyperglycemia, photosensitivity, impotence, RASH, and transient blurred vision
Triamterene with HCTZ
202
Paroxetine HCl
Paxil (XR), Pexeva
203
Highly selective inhibitor of neuronal serotonin uptake (SSRI)
Paroxetine
204
Contact a physician if patient develops leg, foot, or hand swelling or has excessive thirst (drug may cause hyponatremia)
Paroxetine
205
Do not take sooner than every 24 hours
Paroxetine
206
Hydroxyzine HCl
Atarax
207
Antagonizes the H1 (histamine) receptors in peripheral tissues. May also suppress histamine activity in the subcortical region of the CNS.
Hydroxyzine
208
CI in early pregnancy. Use caution in nursing mothers and in patients taking CNS depressants
Hydroxyzine
209
Dicyclomine HCl
Bentyl
210
Causes inhibition of acetylcholine at postganglionic parasympathetic receptor sites in smooth muscle, secretory gland tissue, and to a lesser degree in the CNS.
Dicyclomine
211
CI in patients with urinary tract or intestinal obstruction, intestinal atony, unstable CV status in acute hemorrhage, myasthenia gravis, severe ulcerative colitis, paralytic ileus, or glaucoma, and in infants
Dicyclomine
212
Glimepiride
Amaryl
213
Celecoxib
Celebrex
214
Produces its anti-inflammatory, analgesic, and antipyretic effects by inhibiting prostaglandin synthesis through inhibition of cyclooxygenase-2 (COX-2)
Celecoxib
215
CI in patients who have experienced asthma, urticaria, or allergic-type reactions after taking sulfonamides, aspirin, or NSAIDs. CI in treatment of preoperative pain in the setting of coronary artery bypass graft surgery. May cause an increased risk of serious CV thrombotic events, MI, and stroke
Celecoxib
216
Promptly report any signs of ulcerations and bleeding (intense GI pain, dark stools) to a physician
Celecoxib